NANECH
NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.
Market Cap & Net Worth: NANECH (NANECH)
NANECH (ST:NANECH) has a market capitalization of $651.58K (Skr7.31 Million) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #37481 globally and #613 in its home market, demonstrating a -42.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NANECH's stock price Skr0.02 by its total outstanding shares 304562696 (304.56 Million).
NANECH Market Cap History: 2025 to 2026
NANECH's market capitalization history from 2025 to 2026. Data shows growth from $2.14 Million to $651.58K (0.00% CAGR).
NANECH Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NANECH's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.38x
NANECH's market cap is 4.38 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $2.14 Million | $488.00K | -$15.65 Million | 4.38x | N/A |
Competitor Companies of NANECH by Market Capitalization
Companies near NANECH in the global market cap rankings as of March 19, 2026.
Key companies related to NANECH by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
NANECH Historical Marketcap From 2025 to 2026
Between 2025 and today, NANECH's market cap moved from $2.14 Million to $ 651.58K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr651.58K | -69.54% |
| 2025 | Skr2.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NANECH was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $651.58K USD |
| MoneyControl | $651.58K USD |
| MarketWatch | $651.58K USD |
| marketcap.company | $651.58K USD |
| Reuters | $651.58K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.